CUA Speaker Tour: Theragnostics (Evidence-base for radiopharmaceuticals: Life-prolonging therapies for men with prostate cancer)
DÉTAILS DE L’ACTIVITÉ
CRÉDITS
SESSION #2: Evidence-base for radiopharmaceuticals: Life-prolonging therapies for men with prostate cancer
FEATURED SPEAKER:
Professor Michael Hofman, MBBS, FRACP, FAANMS, FICIS
PET Modality Lead, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging
Director, Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC)
Peter MacCallum Cancer Centre, Melbourne, Australia
Sir Peter MacCallum Department of Oncology, The University of Melbourne